Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

por Sandmaier, Brenda M., Khaled, Samer, Oran, Betül, Gammon, Guy, Trone, Denise, Frankfurt, Olga
Publicado 2017

Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD

por Bethge, Wolfgang, Kerbauy, Fabio R., Santos, Erlinda B., Gooley, Theodore, Storb, Rainer, Sandmaier, Brenda M.
Publicado 2014

Extracorporeal Photopheresis in Addition to Pentostatin in Conditioning for Canine Hematopoietic Cell Transplantation: Role in Engraftment

por Bethge, Wolfgang A., Kerbauy, Fabio R., Santos, Erlinda, Gooley, Ted A, Storb, Rainer, Sandmaier, Brenda M.
Publicado 2010

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy

por Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Publicado 2011

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide

por Navarro, Sandi L., Zheng, Zihan, Randolph, Timothy W., Nakamura, Ryotaro, Sandmaier, Brenda M., Hockenbery, David, McCune, Jeannine S.
Publicado 2022

Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

por Orvain, Corentin, Rodríguez-Arbolí, Eduardo, Othus, Megan, Sandmaier, Brenda M., Deeg, H. Joachim, Appelbaum, Frederick R., Walter, Roland B.
Publicado 2023

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

por Rashidi, Armin, Gao, Fei, Fredricks, David N., Pergam, Steven A., Mielcarek, Marco, Milano, Filippo, Sandmaier, Brenda M., Lee, Stephanie J.
Publicado 2023

High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients

por Jaklič, Alenka, Collins, Carol J., Mrhar, Aleš, Sorror, Mohamed L., Sandmaier, Brenda M., Bemer, Meagan J., Locatelli, Igor, McCune, Jeannine S.
Publicado 2013

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia

por Thakar, Monica S., Bonfim, Carmem, Walters, Mark C., Storb, Rainer, Pasquini, Ricardo, Burroughs, Lauri, Sandmaier, Brenda M., Woolfrey, Ann, Kiem, Hans-Peter
Publicado 2017

Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients

por McCune, Jeannine S., Nakamura, Ryotaro, O’Meally, Denis, Randolph, Timothy W., Sandmaier, Brenda M., Karolak, Aleksandra, Hockenbery, David, Navarro, Sandi L.
Publicado 2022

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and Global Severity

por Aki, Sahika Zeynep, Inamoto, Yoshihiro, Carpenter, Paul A., Storer, Barry E., Sandmaier, Brenda M., Lee, Stephanie J., Martin, Paul J., Flowers, Mary E.D.
Publicado 2016

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute...

por Orvain, Corentin, Wilson, Jacob A., Fang, Min, Sandmaier, Brenda M., Rodríguez-Arbolí, Eduardo, Wood, Brent L., Othus, Megan, Appelbaum, Frederick R., Walter, Roland B.
Publicado 2022

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation

por Ueda Oshima, Masumi, Xie, Hu, Zamora, Danniel, Flowers, Mary E., Hill, Geoffrey R., Mielcarek, Marco B., Sandmaier, Brenda M., Gooley, Ted A., Boeckh, Michael J.
Publicado 2023

Treatment of Fanconi anemia patients using fludarabine and low-dose total body irradiation followed by unrelated donor hematopoietic cell transplantation

por Thakar, Monica S, Kurre, Peter, Storb, Rainer, Kletzel, Morris, Frangoul, Haydar, Pulsipher, Michael A., Leisenring, Wendy, Flowers, Mary Evelyn D, Sandmaier, Brenda M, Woolfrey, Ann, Kiem, Hans-Peter
Publicado 2010

Utility of Treatment-Related Mortality (TRM) Score to Predict Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

por Zarling, Lucas C., Othus, Megan, Sandmaier, Brenda M., Milano, Filippo, Schoch, Gary, Davis, Chris, Bleakley, Marie, Deeg, H. Joachim, Appelbaum, Frederick R., Storb, Rainer, Walter, Roland B.
Publicado 2022

EASIX-1year and late mortality after allogeneic stem cell transplantation

por Kordelas, Lambros, Terzer, Tobias, Gooley, Ted, Davis, Chris, Sandmaier, Brenda M., Sorror, Mohamed, Penack, Olaf, Schaeper, Nigel D. E., Blau, Igor W., Beelen, Dietrich, Radujkovic, Aleksandar, Dreger, Peter, Luft, Thomas
Publicado 2023

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?

por Gallo, Susanna, Woolfrey, Ann E., Burroughs, Lauri M., Storer, Barry E., Flowers, Mary E.D., Hari, Parameswaran, Pulsipher, Michael A., Heimfeld, Shelly, Kiem, Hans-Peter, Sandmaier, Brenda M., Storb, Rainer
Publicado 2016

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferativ...

por Monaco, Federico, Scott, Bart L., Chauncey, Thomas R., Petersen, Finn B., Storer, Barry E., Baron, Frederic, Flowers, Mary E., Deeg, H. Joachim, Maloney, David G., Storb, Rainer, Sandmaier, Brenda M.
Publicado 2019

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell tra...

por Rodríguez-Arbolí, Eduardo, Othus, Megan, Orvain, Corentin, Zarling, Lucas C., Sandmaier, Brenda M., Milano, Filippo, Schoch, Gary, Davis, Chris, Deeg, H. Joachim, Appelbaum, Frederick R., Storb, Rainer, Walter, Roland B.
Publicado 2022

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell...

por Walter, Roland B., Gyurkocza, Boglarka, Storer, Barry E., Godwin, Colin D., Pagel, John M., Buckley, Sarah A., Sorror, Mohamed L., Wood, Brent L., Storb, Rainer, Appelbaum, Frederick R., Sandmaier, Brenda M.
Publicado 2014